-Yiwei Li Researcher Activity Profile

Research Author Detailed Information 

Yiwei Li Publication Rate By Year

Yiwei Li has published 1 paper(s) in 2002, 2 paper(s) in 2006, 11 paper(s) in 2007, for a total of 14 research publications in total.

Yiwei Y Li Author Information

LAST NAME: li

FIRST NAME: yiwei

INITIALS: Y

AFFILIATION:

Papers

Yiwei Li's Publication Record

1. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
2. Clinicopathologic significance of structural alterations of p53 protein in papillary thyroid carcinoma. Year Published: 2002
(Email: chenyifeng@21cn.com)
3. Evidence for reprogramming global gene expression during zinc deficiency in the HUT-78 cell line. Year Published: 2006
Department of Internal Medicine, Division of Hematology, Wayne State University School of Medicine, Detroit, Michigan, USA. fwbeck@med.wayne.edu
4. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Year Published: 2006
Departments of Pathology and Internal Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
5. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. Year Published: 2007
Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
6. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 740 Hudson Webber Cancer Research Center, Detroit, MI 48201, USA. fsarkar@med.wayne.edu
7. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Year Published: 2007
Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
8. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
9. Pancreatic cancer: pathogenesis, prevention and treatment. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 740 Hudson Webber Cancer Research Center, 110 E Warren, Detroit, MI 48201, USA. fsarkar@med.wayne.edu
10. NF-kappaB: a potential target for cancer chemoprevention and therapy. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. fsarkar@med.wayne.edu
11. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University, 9374 Scott Hall, 540 East Canfield, Detroit, MI 48201, USA.
12. NF-kappaB: a potential target for cancer chemoprevention and therapy. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. fsarkar@med.wayne.edu
13. Pancreatic cancer: pathogenesis, prevention and treatment. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 740 Hudson Webber Cancer Research Center, 110 E Warren, Detroit, MI 48201, USA. fsarkar@med.wayne.edu
14. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Year Published: 2007
Department of Pathology, Karmanos Cancer Institute, Wayne State University, 9374 Scott Hall, 540 East Canfield, Detroit, MI 48201, USA.